These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20506446)

  • 1. Modelling lifetime QALYs and health care costs from different drinking patterns over time: a Markov model.
    Barbosa C; Taylor B; Godfrey C; Rehm J; Parrott S; Drummond C
    Int J Methods Psychiatr Res; 2010 Jun; 19(2):97-109. PubMed ID: 20506446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cost Effectiveness of Nalmefene for Reduction of Alcohol Consumption in Alcohol-Dependent Patients with High or Very High Drinking-Risk Levels from a UK Societal Perspective.
    Brodtkorb TH; Bell M; Irving AH; Laramée P
    CNS Drugs; 2016 Feb; 30(2):163-77. PubMed ID: 26879458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-utility analysis of an alcohol policy in Thailand: a case study of a random breath testing intervention.
    Vichitkunakorn P; Khampang R; Leelahavarong P; Nontarak J; Assanangkornchai S
    BMC Health Serv Res; 2024 Jun; 24(1):739. PubMed ID: 38886718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model.
    Laramée P; Brodtkorb TH; Rahhali N; Knight C; Barbosa C; François C; Toumi M; Daeppen JB; Rehm J
    BMJ Open; 2014 Sep; 4(9):e005376. PubMed ID: 25227627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health impact and economic burden of alcohol consumption in India.
    Jyani G; Prinja S; Ambekar A; Bahuguna P; Kumar R
    Int J Drug Policy; 2019 Jul; 69():34-42. PubMed ID: 31055044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the Societal Benefits of THA After Accounting for Work Status and Productivity: A Markov Model Approach.
    Koenig L; Zhang Q; Austin MS; Demiralp B; Fehring TK; Feng C; Mather RC; Nguyen JT; Saavoss A; Springer BD; Yates AJ
    Clin Orthop Relat Res; 2016 Dec; 474(12):2645-2654. PubMed ID: 27699631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of alcohol-related ill health in the United Kingdom.
    Balakrishnan R; Allender S; Scarborough P; Webster P; Rayner M
    J Public Health (Oxf); 2009 Sep; 31(3):366-73. PubMed ID: 19493915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of therapies to treat alcohol use disorders.
    Rehm J; Barbosa C
    Expert Rev Pharmacoecon Outcomes Res; 2018 Feb; 18(1):43-49. PubMed ID: 29022750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost of alcohol in California.
    Rosen SM; Miller TR; Simon M
    Alcohol Clin Exp Res; 2008 Nov; 32(11):1925-36. PubMed ID: 18717655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling the cost effectiveness of antidepressant treatment in primary care.
    Revicki DA; Brown RE; Palmer W; Bakish D; Rosser WW; Anton SF; Feeny D
    Pharmacoeconomics; 1995 Dec; 8(6):524-40. PubMed ID: 10160081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of lopinavir/ritonavir tablets compared with atazanavir plus ritonavir in antiretroviral-experienced patients in the UK, France, Italy and Spain.
    Simpson KN; Jones WJ; Rajagopalan R; Dietz B
    Clin Drug Investig; 2007; 27(12):807-17. PubMed ID: 18020538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic Decision Model for First-Time Traumatic Patellar Dislocations in Adolescents.
    Nwachukwu BU; So C; Schairer WW; Shubin Stein BE; Strickland SM; Green DW; Dodwell ER
    Am J Sports Med; 2017 Aug; 45(10):2267-2275. PubMed ID: 28463547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated effect of alcohol pricing policies on health and health economic outcomes in England: an epidemiological model.
    Purshouse RC; Meier PS; Brennan A; Taylor KB; Rafia R
    Lancet; 2010 Apr; 375(9723):1355-64. PubMed ID: 20338629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of hip protector use on a geriatric ward in Germany: a Markov model.
    Stollenwerk B; Bartmus T; Klug F; Stock S; Müller D
    Osteoporos Int; 2015 Apr; 26(4):1367-79. PubMed ID: 25572047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preference weights for the spectrum of alcohol use in the U.S. Population.
    Chavez LJ; Bradley K; Tefft N; Liu CF; Hebert P; Devine B
    Drug Alcohol Depend; 2016 Apr; 161():206-13. PubMed ID: 26900145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic Decision Model Suggests Total Shoulder Arthroplasty is Superior to Hemiarthroplasty in Young Patients with End-stage Shoulder Arthritis.
    Bhat SB; Lazarus M; Getz C; Williams GR; Namdari S
    Clin Orthop Relat Res; 2016 Nov; 474(11):2482-2492. PubMed ID: 27457626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the cost effectiveness of pharmacotherapy or surgery (laparoscopic fundoplication) in the treatment of GORD.
    Bojke L; Hornby E; Sculpher M;
    Pharmacoeconomics; 2007; 25(10):829-41. PubMed ID: 17887805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling lifetime costs and health outcomes attributable to secondhand smoke exposure at home among Korean adult women.
    Lee J; Han AR; Choi D; Lim KM; Bae S
    BMJ Open; 2017 May; 7(5):e013292. PubMed ID: 28515183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AESOPS: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of opportunistic screening and stepped care interventions for older hazardous alcohol users in primary care.
    Watson JM; Crosby H; Dale VM; Tober G; Wu Q; Lang J; McGovern R; Newbury-Birch D; Parrott S; Bland JM; Drummond C; Godfrey C; Kaner E; Coulton S;
    Health Technol Assess; 2013 Jun; 17(25):1-158. PubMed ID: 23796191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analyses and modelling the lifetime costs and benefits of health-behaviour interventions.
    Graves N; McKinnon L; Reeves M; Scuffham P; Gordon L; Eakin E
    Chronic Illn; 2006 Jun; 2(2):97-107. PubMed ID: 17175653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.